penicillanic acid has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emiroğlu, M; Köksal, Y; Köse, D | 1 |
| Kelsey, SM; Newland, AC; Pocock, CE; Shaw, E; Weinhardt, B | 1 |
1 trial(s) available for penicillanic acid and Lymphoma
| Article | Year |
|---|---|
Piperacillin/tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; beta-Lactamase Inhibitors; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam | 1992 |
1 other study(ies) available for penicillanic acid and Lymphoma
| Article | Year |
|---|---|
High-risk febrile neutropenia and its management in children with solid tumors and lymphoma.
Topics: Amikacin; Anti-Bacterial Agents; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Child; Febrile Neutropenia; Female; Humans; Imipenem; Lymphoma; Male; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protein Precursors | 2015 |